SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Gold/Mining/Energy : ECHARTERS
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: E. Charters who wrote (3454)4/29/2011 5:48:32 AM
From: Logain Ablar  Read Replies (2) of 3744
 
Hi Eric:

If only they let the diagnosis be clinical. The infectious disease society of america guidelines are clinical only if there is the em rash. Then elisa screening test (over 35% false negative) before western blot test (requiring 5 reactive bands when it should only be 1).

The spirochete has proven to be hard to kill.

Of course I'm biased as my daugher has gone through the controversy of diagnosing and treating the disease.

I think the Lyme treatment in the U.S. must be like normal medical care in Canada. Impossible to obtain an appointment with a LLMD and then you have to pay out of pocket as its not covered by insurance.

Best,

Tim
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News